Right-sided colorectal cancers show that the expression of the HSPGs glypican-1,-3, and -6 and betaglycan are altered in non-metastatic tumors, whereas in metastatic tumors, only glypican-1 and SDC1 are modified. This evidence concerns the gene TGFBR3 and metastatic neoplasm.